Out-licensing

We are eager to out-license our Nuntius biotechnology to mRNA players for the development of mRNA vaccines and therapies.

Last news

photo labo 2

Messenger Biopharma licenses its Nuntius biotechnology to mRNA players

posted October 28, 2024

Read More

Recent Search Keywords